Form DEF 14A Tevogen Inc. For: 3 August
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Tevogen Bio Holdings Inc (TVGN)
Tevogen Bio Holdings Inc stock price live, this page displays NASDAQ TVGN stock exchange data. View the TVGN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Tevogen Bio Holdings Inc real time stock price chart below.
What Is the Tevogen Bio Holdings Inc Stock Price Today?
The Tevogen Bio Holdings Inc stock price today is 6.315.
What Is the Stock Symbol for Tevogen Bio Holdings Inc?
The stock symbol for Tevogen Bio Holdings Inc is "TVGN."
What Stock Exchange Does Tevogen Bio Holdings Inc Trade On?
Tevogen Bio Holdings Inc is listed and trades on the NASDAQ stock exchange.
Is Tevogen Bio Holdings Inc a Good Stock to Buy?
Determining whether Tevogen Bio Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TVGN quote. (ISIN: US88165K2006)
What Is the Tevogen Bio Holdings Inc Stock Price Today?
The Tevogen Bio Holdings Inc stock price today is 6.315.
What Is the Stock Symbol for Tevogen Bio Holdings Inc?
The stock symbol for Tevogen Bio Holdings Inc is "TVGN."
What Stock Exchange Does Tevogen Bio Holdings Inc Trade On?
Tevogen Bio Holdings Inc is listed and trades on the NASDAQ stock exchange.
Is Tevogen Bio Holdings Inc a Good Stock to Buy?
Determining whether Tevogen Bio Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TVGN quote. (ISIN: US88165K2006)
6.315
-0.155(-2.40%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.315
6.580
52 wk Range
3.636
51.000
TVGN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.3156.580
52 wk Range
3.63651.000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TVGN Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
0.000
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Form S-3 Tevogen Bio Holdings Inc For: 12 June- Investing.com
Form PRE 14A Tevogen Bio Holdings Inc. For: 23 July- Investing.com
Form 13D/A Tevogen Bio Holdings Inc. For: 14 July- Investing.com
- Form DEF 14A Tevogen Inc. For: 3 August
- Investing.com
- Form PRE 14A Tevogen Bio Holdings Inc. For: 23 July
- Investing.com
- Form 13D/A Tevogen Bio Holdings Inc. For: 14 July
- Investing.com
Form 4 Tevogen Bio Holdings Inc For: 10 July- Investing.com
Form 4 Tevogen Bio Holdings Inc For: 10 July- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 0.000
Earnings
Latest Release
May 15, 2026
EPS / Forecast
-1.61 / --
Revenue / Forecast
-- / --
Compare TVGN to Peers and Sector
Metrics to compare | TVGN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTVGNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.3x | −4.1x | −0.3x | |
PEG Ratio | −0.03 | −0.17 | 0.00 | |
Price/Book | −1.5x | 2.6x | 2.6x | |
Price / LTM Sales | - | 20.1x | 3.1x | |
Upside (Analyst Target) | - | 85.0% | 48.3% | |
Fair Value Upside | Unlock | 18.4% | 6.7% | Unlock |
Tevogen Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients; and in Phase 1 clinical trial to treat acute SARS-CoV-2 patients with B-cell cancer immune suppression, and other B cell immune suppressed acute SARS-CoV-2 patients with a B cell cancer indication, as well as Long COVID prevention and treatment. It is also developing TVGN 920, a preclinical trial drug for treating cervical cancer; TVGN 960, a preclinical trial drug for treating oropharyngeal cancer; TVGN 601, a preclinical trial drug for treating multiple sclerosis; TVGN 930, a preclinical trial drug for treating Epstein-Barr virus associated lymphomas; and TVGN 116, a product candidate targeted at hepatitis B. It also offers artificial intelligence platform for drug development. Tevogen Inc. was formerly known as Tevogen Bio Holdings Inc. and changed its name to Tevogen Inc. in July 2026. The company was incorporated in 2020 and is headquartered in Warren, New Jersey.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Tevogen Bio Holdings (TVGN) Stock Price Today?
The Tevogen Bio Holdings stock price today is 6.315 USD.
What Stock Exchange Does Tevogen Bio Holdings Trade On?
Tevogen Bio Holdings is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Tevogen Bio Holdings?
The stock symbol for Tevogen Bio Holdings is "TVGN."
What Is the Tevogen Bio Holdings Market Cap?
As of today, Tevogen Bio Holdings market cap is 27.300M USD.
What Is Tevogen Bio Holdings's Earnings Per Share (TTM)?
The Tevogen Bio Holdings EPS (TTM) is -6.484.
From a Technical Analysis Perspective, Is TVGN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Tevogen Bio Holdings Stock Split?
Tevogen Bio Holdings has split 1 times.
What is the current trading status of Tevogen Bio Holdings (TVGN)?
As of Aug 13, 2026, Tevogen Bio Holdings (TVGN) is trading at a price of 6.315 USD, with a previous close of 6.470 USD. The stock has fluctuated within a day range of 6.315 USD to 6.580 USD, while its 52-week range spans from 3.636 USD to 51.000 USD.
What Is the TVGN Premarket Price?
TVGN's last pre-market stock price is 6.150 USD. The pre-market share volume is 20.000, and the stock has decreased by -0.320, or -4.950%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.